Cellular immune modulation

Cellular immune modulation is a broad therapeutic strategy aimed at regulating the immune system's activity to treat a variety of pathological conditions, including malignancy, autoimmunity, and chronic inflammation (StatPearls: Immunomodulation). Rather than representing a single molecular target, it encompasses a diverse range of mechanisms that either stimulate or suppress immune cell populations such as T lymphocytes, B lymphocytes, and myeloid cells (NIH: Cancer Immunotherapy). In the context of oncology, this often involves the use of immune checkpoint inhibitors to overcome tumor-induced immunosuppression, while in autoimmune diseases, it involves the use of immunosuppressants or cytokine antagonists to restore self-tolerance (Nature Reviews Drug Discovery: Immunomodulatory therapies). Because the term describes a physiological outcome or a class of pharmacological interventions rather than a specific protein or receptor, it is categorized as a functional process in drug discovery. The clinical application of cellular immune modulation requires precise control to avoid systemic toxicities such as cytokine release syndrome or severe opportunistic infections.

Other names

ImmunomodulationImmune system modulationCellular immunotherapy

Modulation of immune cell activity through various pathways including checkpoint inhibition, cytokine signaling, and lymphocyte activation or suppression.